Drug delivery, formulation


Related News

BIA 10-2474 is a fatty acid hydrolase (FAAH) inhibitor. (Image: iStock/JK1991)

New insight into BIA 10-2474 clinical trial shines light on preclinical testing

The facility combines Covance Drug Development and LabCorp Diagnostics capabilities. (Photo: Business Wire)

Covance opens companion diagnostics laboratory

LabConnect provides central laboratory and scientific support services to biopharmaceutical companies. (Image: iStock/uris)

After doubling in size, LabConnect secures $24.5m investment

See More Headlines